Cutting-Edge Genomic Research

Explore breakthrough studies, CRISPR applications, and transformative discoveries in gene editing technology

Research Articles

The Double Agent: How a Common Cancer Mutation Betrays Our Cellular Defenses

Discover how TP53 missense mutations act as molecular double agents in myeloid malignancies, sabotaging our cellular defenses through dominant-negative effects.

Lucas Price
Oct 02, 2025

Popular Articles